The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

Celebrex belongs to the Cox-2 inhibitors ... FDA has necessitated a warning on the drug’s label. Cox-2 inhibitors belong to the latest generation of the painkillers called NSAIDs (nonsteroidal ...

Nearly a decade after reports first surfaced linking the prescription pain reliever celecoxib (Celebrex ... warned against the drug for people at risk of heart problems, about 11 million ...

Celebrex (celecoxib) and ibuprofen are both ... with a history of stomach ulcers or sensitivities to other NSAIDs. The drug's ...

Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

Pharmacia already has a strong presence in the arthritis market with the blockbuster anti-inflammatory drug Celebrex. Celltech's share rose 82p to £14.17 ($20.83) following the news.

Compared to other NSAIDs, Celebrex had a lower risk of causing GI bleeding, GI ulcers, swelling, and high blood pressure, according to a 2013 article in Expert Opinion on Drug Safety. However ...